This new class of 7-MEOTA-adamantyl amine heterodimers with different linker sizes was prepared and tested for their ability to inhibit both targeted cholinesterases that are involved in proposed cholinergic hypothesis of AD. Here, BCHE is linked to Alzheimer disease.